Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ablation Frontiers logo — Pioneering solutions for cardiac arrhythmias with innovative...

Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF technology.

Founded 2004 Series C Total: $40.47M Biopharma, Biotechnology +4

General Information

Company Name Ablation Frontiers
Founded Year 2004
Industries Biopharma, Biotechnology, Health Care +3
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Ablation Frontiers. To contact Ablation Frontiers, visit ablationfrontiers.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ablation Frontiers compare?

A PDF of Ablation Frontiers and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ablation Frontiers soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ablation Frontiers

Ablation Frontiers is a Carlsbad, California-based medical device company founded in 2004. The company focuses on developing innovative catheter systems and advanced RF technology to assist individuals with atrial fibrillation (AF) and other cardiac arrhythmias. In 2006, they obtained CE Mark approval to market their catheter system and the GENius™ Radiofrequency (RF) Generator in the European Union for the treatment of supraventricular arrhythmias and atrioventricular node ablation. Ablation Frontiers is currently conducting a clinical trial under a United States Food and Drug Administration (FDA) investigational device exemption (IDE) to seek approval for its catheter system for the treatment of permanent/long-standing persistent/chronic AF in the United States. It's important to note that Ablation Frontiers' products are not yet approved for marketing or sales in the US. The company's last investment was a $21.80M Series C investment on 17 July 2007, with participation from notable investors such as Aberdare Ventures, Novartis Venture Fund, Versant Ventures, Hexagon Investments, affinity ventures ag, Pequot Capital, and Trellis Health Ventures. Ablation Frontiers operates within the biopharma, biotechnology, health care, health and wellness, manufacturing, and medical devices sectors.

Business keywords: cardiac arrhythmias, catheter systems, RF technology, AF treatment, CE Mark approval, FDA clinical trial, innovation, regulatory approval, Ablation Frontiers, RF generator, chronic AF, clinical research, cardiology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $21.80M 7
Aberdare Ventures Novartis Venture Fund Versant Ventures
Aberdare Ventures, Novartis Venture Fund +5
17 Jul 2007
Series B $15.07M 2
Versant Ventures
Versant Ventures, Pequot Capital
24 Feb 2006
Series A $3.60M 1
Versant Ventures
Versant Ventures
22 Jun 2004

Ablation Frontiers Alternatives & Competitors

View All Alternatives
Ablation Frontiers vs
CardioFocus
CardioFocus

Lesion Creation at the Speed of Light

Venture round
65 employees
Biotechnology, Health Care
Compare Ablation Frontiers vs CardioFocus
Ablation Frontiers vs
Avenu Medical
Avenu Medical United States

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in...

Venture round
10 employees
Health Care, Medical Devices
Ablation Frontiers vs
Novian Health
Novian Health United States

A LEADING COMPANY IN IMAGE-GUIDED LASER TUMOR THERAPY

Convertible Note
9 employees
Health Care, Health and Wellness
Also compare with: Ablation Frontiers vs Vektor Medical, Inc. Vektor Medical, Inc. View all alternatives

FAQ About Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF technology.
Ablation Frontiers was founded in 2004.
Ablation Frontiers operates in Biopharma, Biotechnology, Health Care, Health and Wellness, Manufacturing and Medical Devices. Its work centres on cardiac arrhythmias, catheter systems, RF technology and AF treatment.
Ablation Frontiers has completed 3 funding rounds, raising a total of $40.47M. The latest funding stage is Series C.
Top alternatives and competitors to Ablation Frontiers include CardioFocus, Avenu Medical, Novian Health, Vektor Medical, Inc., Endosense. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ablation Frontiers and CardioFocus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ablation Frontiers, https://bouncewatch.com/company/ablation-frontiers, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout